Blood coagulation factor XIII: A multifunctional transglutaminase

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Factor XIII is a pro-enzyme of plasma transglutaminase consisting of two enzymatic A subunits and two non-catalytic B subunits, and platelet transglutaminase consisting of two enzymatic A subunits. FXIII plays a critical role in the generation of a stable hemostatic plug, wound healing, maintaining pregnancy, angiogenesis, apoptosis and bacterial immobilization. FXIII catalyzes intermolecular cross-linking reactions between fibrin monomers and α2- antiplasmin. These reactions increase the mechanical strength of the fibrin clot and its resistance to proteolytic degradation. Congenital FXIII deficiency is a rare autosomal recessive disorder, most cases of which are caused by defects in the FXIII-A gene, leading to a bleeding tendency. An autoimmune hemophilia-like disease is caused by anti-FXIII antibodies. Platelet surface FXIII-A2 is involved in fibrin translocation to lipid rafts and outside-in signaling, leading to clot retraction. FXIII-A2-mediated protein cross-linking is associated with assembly of the extracellular matrix on a variety of cell surfaces in physiological events such as differentiation.

Cite

CITATION STYLE

APA

Hayashi, M., & Kasahara, K. (2016). Blood coagulation factor XIII: A multifunctional transglutaminase. In Transglutaminases: Multiple Functional Modifiers and Targets for New Drug Discovery (pp. 333–346). Springer Japan. https://doi.org/10.1007/978-4-431-55825-5_15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free